Positive study results for Eisai-Biogen lifted the prospects for its medication and one from Eli Lilly—although regulators will have to weigh risks.
Welcome! Log into your account
Recover your password
A password will be e-mailed to you.
Newest Alzheimer's Drugs Take Big but Fraught Step Toward Approval